Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.

Saji, T; Ozawa, Y; Ishikita, T; Matsuura, H; Matsuo, N

Saji, T; Ozawa, Y; Ishikita, T; Matsuura, H; Matsuo, N.

Affiliation

Saji T; Department of Pediatrics, Toho University, Tokyo, Japan.

Am J Cardiol ; 78(2): 244-7, 1996 Jul 15.

Article in En | MEDLINE | ID: mdl-8712155

Subject(s)

Epoprostenol/analogs & derivatives; Hemodynamics/drug effects; Hypertension, Pulmonary/physiopathology; Platelet Aggregation Inhibitors/pharmacology; Vasodilator Agents/pharmacology; Adult; Child; Epoprostenol/pharmacology; Epoprostenol/therapeutic use; Female; Humans; Hypertension, Pulmonary/drug therapy; Infant; Male; Middle Aged; Platelet Aggregation Inhibitors/therapeutic use; Treatment Outcome; Vasodilator Agents/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vasodilator Agents / Platelet Aggregation Inhibitors / Epoprostenol / Hemodynamics / Hypertension, Pulmonary Limits: Adult / Child / Female / Humans / Infant / Male / Middle aged Language: En Journal: Am J Cardiol Year: 1996 Document type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links